Condition 1: Bipolar disorder. Condition 2: Obsessive-Compulsive disorder. Bipolar affective disorder Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: The study is a double blind clinical trial. Interventional Group (Group A) is 20 people that receive Aripiprazole in addition to Lithium and Benzodiazepine (if necessary). Administra
Treatment - Drugs
The study is a double blind clinical trial. Interventional Group (Group A) is 20 people that receive Aripiprazole in addition to Lithium and Benzodiazepine (if necessary). Administrator is doing Obs
This study is a double blind clinical trial. Control Group (Group B) is 20 people that receive Placebo in addition to Lithium and Benzodiazepine (if necessary). Administrator is doing obsession seve
Sponsors
Vice chancellery for Research Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with a diagnosis of bipolar disorder according to the DSM IV TR criteria; Yale Brown Score more than 16 at baseline; No important medical condition Exclusion criteria: Patients were not in acute phase of depression and mania; Important medical condition (cardiovascular, Respirator, renal, Gastrointestinal disease); Pregnancy; Yale Brown Score less than 16 at baseline
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Obsession severity. Timepoint: Weeks 0 and 4 and 8. Method of measurement: Yale Brown Test (Y-BOCS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Side edffect. Timepoint: Weeks 4 and 8. Method of measurement: Side effect list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Ehsaei
Department of Psychiatry, Siraz University of Medical Sciences
Outcome results
None listed